The first hospital of China Medical University/Oncology Department
Shenyang, Liaoning, China
Hospital in Shenyang
Liaoning, Shenyang, Heping District, Shenyang, 南京北街155
About The first hospital of China Medical University/Oncology Department
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at The first hospital of China Medical University/Oncology Department
During the past decade, The first hospital of China Medical University/Oncology Department conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on
average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Standard Chemotherapy Compared With High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer
1995-11-01
1999-06-01
Completed
600
High-Dose or Low-Dose Interferon Alfa Compared With No Further Therapy Following Surgery in Treating Patients With Stage III Melanoma
1996-04-01
Unknown status
1,000
Combination Chemotherapy Given With Radiation Therapy or Radiation Therapy Alone in Treating Patients With Early-Stage Hodgkin's Disease
1997-01-01
Unknown status
400
Radiation Therapy Compared With Chemotherapy in Treating Patients With Stage I Testicular Cancer
1998-04-01
2005-07-01
Completed
800
Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis
1997-06-01
Completed
212
Chemotherapy Plus Interferon Alfa Alone or With Radiation Therapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's Lymphoma
1997-03-01
Terminated
469
Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer
1997-12-01
2009-03-01
Completed
45
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at The first hospital of China Medical University/Oncology Department
According to Clinical.Site data, the most researched conditions in "The first hospital of China Medical University/Oncology Department" are
"Breast Neoplasms" (1 trials) and "NSCLC (Non-small Cell Lung Cancer)" (1 trials). Many other conditions were trialed in "The first hospital of China Medical University/Oncology Department" in a lesser frequency.
Clinical Trials Intervention Types at The first hospital of China Medical University/Oncology Department
Most popular intervention types in "The first hospital of China Medical University/Oncology Department" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Crizotinib" (1 trials), "Letrozole" (1 trials), "Palbociclib" (1 trials), "Pemetrexed/Carboplatin" (1 trials) and "Pemetrexed/Cisplatin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at The first hospital of China Medical University/Oncology Department
The vast majority of trials in "The first hospital of China Medical University/Oncology Department" are
1 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at The first hospital of China Medical University/Oncology Department
Currently, there are NaN active trials in "The first hospital of China Medical University/Oncology Department".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in The first hospital of China Medical University/Oncology Department,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in The first hospital of China Medical University/Oncology Department, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".